Form 4: Alkami Technology CFO W. Bryan Hill Executes Stock Option Exercise and Sale
SEC Form 4 Filing
W. Bryan Hill, CFO of Alkami Technology, Inc., exercised stock options and sold shares of common stock on September 23 and 24, 2024, according to a Form 4 filing with the SEC.
Summary
- W. Bryan Hill, the Chief Financial Officer of Alkami Technology, Inc., engaged in transactions involving the company's stock on September 23 and 24, 2024.
- Hill exercised stock options to acquire 55,046 shares on September 23 and 44,954 shares on September 24, both at an exercise price of $2.34 per share.
- Concurrently, Hill sold 55,046 shares on September 23 at a weighted average price of $31.1861 and 44,954 shares on September 24 at a weighted average price of $30.9182.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2024.
- Following these transactions, Hill directly owns 471,403 shares of Alkami Technology, Inc.
- Hill also holds options to purchase 344,954 shares and 300,000 shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock option exercises and sales by the CFO.
Industry Context
This filing is a routine disclosure of insider transactions, which are common among executives of publicly traded companies. The use of a 10b5-1 trading plan suggests that these transactions were pre-planned and not based on any material non-public information.
Comparison to Industry Standards
- Insider trading activity is a common occurrence in publicly listed companies.
- Executives often use Rule 10b5-1 trading plans to avoid accusations of trading on non-public information, which is a standard practice.
- Comparable companies such as Blend Labs, nCino, and DLocal also have executives who regularly file Form 4s related to stock option exercises and sales.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
- The CFO's actions could be interpreted as a sign of confidence or lack thereof, although the 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| March 11, 2024 | Date of adoption of Rule 10b5-1 trading plan |
| September 23, 2024 | Date of stock option exercise and sale of shares |
| September 24, 2024 | Date of stock option exercise and sale of shares |
| September 25, 2024 | Date of signature on the Form 4 filing |
| April 01, 2029 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.